China will reduce the Value Added Tax on 21 rare disease treatments to 3%, starting March 1. CStone Pharma, a Suzhou oncology company, plans to raise $304 million in its Hong Kong IPO at a …
( read original story …)
Home BUSINESS Week In Review: CStone’s Hong Kong IPO To Raise $304 Million At $1.5 Billion Valuation Next Week
ADVERTISEMENT
Categories
Beijing
22°
overcast clouds
humidity: 21%
wind: 1m/s SW
H 22 • L 20
Weather from OpenWeatherMap
Recent Posts
- ‘China’s Cape Canaveral’ is booming, fueled by moon mission and space program 04/05/2024
- China’s Zeekr plans to raise up to $368 mln in US IPO 04/05/2024
- China sends a probe to get samples from the less-explored far side of the moon 04/05/2024
- Apple’s China sales tell a different story than what analysts have heard for months. Where is the disconnect? 04/05/2024
- Putin’s Strategy Under Threat as China Mulls Major Economic Shift 04/05/2024
- China’s Zeekr seeks up to $5.13 billion valuation in US IPO 04/05/2024
- Interview: China’s import expo unique opportunity for Egyptian firms: Egyptian business leader 04/05/2024
- Adm. Sam Paparo Takes Charge of Indo-Pacific Command as China Extends Influence in the Region 04/05/2024
- China’s Zeekr plans to raise up to $368 million in US IPO 04/05/2024
- China’s latest mission could reveal the secrets of the moon’s ‘hidden side’ 04/05/2024
- Durian duel: Malaysia to enter fray to export the spiky fruit to China, alongside Thailand, Vietnam 04/05/2024
- China’s IPO Drought Worsens 04/05/2024